Concepedia

Swarupa G. Kulkarni

SG

12

Publications

955

Citations

11

H-Index

1996

Active since

Affiliations

University of Louisiana at Monroe(Current)

Novartis (United States)

Novartis (Switzerland)

National Center for Toxicological Research

Tris Pharma (United States)

Swarupa G. Kulkarni is an author at University of Louisiana at Monroe specializing in medicine, cell biology, and pharmacology.

Top concepts

Publications per year

1996–2023

12

Publications

12

GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained <i>In Vivo</i> Pathway Inhibition

Aidan G. Gilmartin, Maureen R. Bleam, Arthur Groy et al. · Clinical Cancer Research · 2011 · 590 citations · Full text

Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors

Lecia V. Sequist, Phillippe A. Cassier, Andréa Varga et al. · Cancer Research · 2014 · 76 citations

, , +19

Abstract 3790: Preclinical profile of LGX818: A potent and selective RAF kinase inhibitor

Darrin D. Stuart, Nanxin Li, Daniel J. Poon et al. · Cancer Research · 2012 · 52 citations

, , +17

Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults

Sara Armani, Lillian Ting, Nicholas Sauter et al. · Clinical Drug Investigation · 2017 · 39 citations · Full text

Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors

Lecia V. Sequist, Phillippe A. Cassier, Andréa Varga et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) · 2014 · 37 citations

, , +7

Rows per page

1–5 of 12